The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Krieg Arthur M since 2006.
This trader's CIK number is 1335659.
At the time of last reporting, Krieg Arthur M was the Chief Scientific Officer of Checkmate Pharmaceuticals, Inc.. (stock ticker symbol CMPI).
Also see all insider trading activities at Checkmate Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2021 | CMPI | 84,744 | $806,084 | 0 | $0 | 0 | $0 |
2020 | CMPI | 10,393 | $151,836 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | COLY | 0 | $0 | 21,070 | $39,822 | 0 | $0 |
2006 | COLY | 0 | $0 | 31,332 | $65,559 | 21,000 | $24,149 |
1. Checkmate Pharmaceuticals, Inc. (CMPI)
2. Coley Pharmaceutical Group, Inc. (COLY)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-06-18 | CMPI | Buy | 7,224 | 6.04 | 43,632 |
2021-06-16 | CMPI | Buy | 3,578 | 6.18 | 22,112 |
2021-05-18 | CMPI | Buy | 25,001 | 6.97 | 174,256 |
2021-03-29 | CMPI | Buy | 33,220 | 11.17 | 371,067 |
2021-03-25 | CMPI | Buy | 10,036 | 12.35 | 123,944 |
2021-03-26 | CMPI | Buy | 3,484 | 12.15 | 42,330 |
2021-01-27 | CMPI | Buy | 1,701 | 13.05 | 22,198 |
2021-01-19 | CMPI | Buy | 500 | 13.09 | 6,545 |
2020-12-29 | CMPI | Buy | 443 | 14.16 | 6,272 |
2020-12-22 | CMPI | Buy | 5,103 | 14.64 | 74,707 |
2020-12-15 | CMPI | Buy | 42 | 14.49 | 608 |
2020-12-16 | CMPI | Buy | 4,805 | 14.62 | 70,249 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-08-29 | COLY | Sale | 21,070 | 1.89 | 39,822 |
2006-12-07 | COLY | Sale | 18,122 | 2.24 | 40,593 |
2006-10-13 | COLY | Sale | 13,210 | 1.89 | 24,966 |
2005-11-29 | COLY | Option Ex | 21,000 | 1.15 | 24,149 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Krieg Arthur M (Chief Scientific Officer of Checkmate Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.